Best Melanoma oncologists in Spain: TOP 9 doctors

• Oncologist specializing in melanoma treatment with over 20 years of experience.
• Expert in surgical excision, immunotherapy, targeted therapy, radiation therapy, and chemotherapy for melanoma.
• Has experience practicing at medical institutions in Spain, the USA, and Germany.
• Member of the European Society for Medical Oncology (ESMO) and American Society of Clinical Oncology (ASCO).
• Fluent in English, Spanish, and German, enabling effective communication with patients.

• Specializes in melanoma treatment with a focus on immunotherapy at Vall d'Hebron University Hospital.
• Participated in pivotal trials leading to the approval of Pembrolizumab, Nivolumab, and Ipilimumab for metastatic melanoma.
• Utilizes standard melanoma treatments: surgery, radiation, targeted therapy, chemotherapy, and immunotherapy.
• Has international experience at medical institutions in Spain.
• Member of the Melanoma Unit at Vall d'Hebron Institute of Oncology (VHIO).

• Dr. López-Ibor specializes in melanoma treatment using surgery, immunotherapy, targeted therapy, and radiation.
• She completed her medical degree at Complutense University of Madrid and a doctorate at the University of Barcelona.
• She received international training in Pediatric Hematology and Oncology at the University of Maryland, USA.
• She directs the Pediatric Hematology and Oncology Unit at HM Montepríncipe Hospital in Madrid.
• She is a member of numerous professional organizations and an author of many scientific publications.

Dr. Sullivan graduated in Medicine and Surgery from the National University of Rosario in 2005, specializing in Medical Oncology through the MIR at the Santa Creu i Sant Pau Hospital (HSCiSP, 2012) in Barcelona.

She received a post-MIR scholarship from the Ministry of Interior from HSPiSP (2012) and then a pre-doctoral scholarship from ISCiii (Rio Hortega – 2013-2015).

In 2014, he moved to Paris where he obtained a DUERTECC diploma at the Gustave Roussy University Hospital (Villejuif), followed by an ESMO scholarship (Georges Mathé Translator Scholarship), which he received in 2016.

Since January 2017, he has been working on the staff of the Medical Oncology Department of the HSCiSP. In the same year, he obtained his PhD from the Autonomous University of Barcelona.

Since 2015, he has been a member of the Board of Directors of the Spanish Lung Cancer Group (GECP). And since 2022, he has been the coordinator of the HSCiSP Committee on Neuroendocrine Tumors.

In November 2021, she joined the IOR Medical Oncology Service and is actively involved in various research projects in the Pangea Lab under the supervision of Dr. Molina.

Dr. Sullivan is involved in several clinical trials in lung cancer and neuroendocrine tumors, many of which have been presented at various international scientific meetings.

She has participated in national and international conferences and is an author and co-author of research articles published in influential journals.

She is currently a member of the Spanish Society of Medical Oncology (SEOM), GECP, European Society of Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO), European Organization for Research and Treatment of Cancer (EORTC) and the Spanish Group of Neuroendocrine and Endocrine Tumors (GETNE).